MSK Stock Overview
An investment holding company, engages in the manufacture, marketing, and sale of medical devices in the People’s Republic of China, North America, Europe, rest of Asia, South America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
MicroPort Scientific Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.75 |
| 52 Week High | HK$1.52 |
| 52 Week Low | HK$0.51 |
| Beta | 0.11 |
| 11 Month Change | -0.66% |
| 3 Month Change | 27.12% |
| 1 Year Change | -50.66% |
| 33 Year Change | -82.21% |
| 5 Year Change | -12.28% |
| Change since IPO | 1.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| MSK | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.7% | -4.5% | -0.6% |
| 1Y | -50.7% | -3.2% | 9.6% |
Return vs Industry: MSK underperformed the German Medical Equipment industry which returned -3.8% over the past year.
Return vs Market: MSK underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| MSK volatility | |
|---|---|
| MSK Average Weekly Movement | 13.7% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MSK's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: MSK's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 6,987 | Maxwell Chang | www.microport.com |
MicroPort Scientific Corporation, an investment holding company, engages in the manufacture, marketing, and sale of medical devices in the People’s Republic of China, North America, Europe, rest of Asia, South America, and internationally. The company’s Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related delivery systems, balloon catheters, accessories, and active devices. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma products, and other professional implants and instruments.
MicroPort Scientific Corporation Fundamentals Summary
| MSK fundamental statistics | |
|---|---|
| Market cap | €1.41b |
| Earnings (TTM) | -€391.74m |
| Revenue (TTM) | €976.71m |
1.4x
P/S Ratio-3.6x
P/E RatioIs MSK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MSK income statement (TTM) | |
|---|---|
| Revenue | US$1.03b |
| Cost of Revenue | US$452.56m |
| Gross Profit | US$574.26m |
| Other Expenses | US$986.10m |
| Earnings | -US$411.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 55.93% |
| Net Profit Margin | -40.11% |
| Debt/Equity Ratio | 121.5% |
How did MSK perform over the long term?
See historical performance and comparison